Alteogen-Sandoz Sign Agreement to Jointly Develop Hyaluronidase
Planned for use in various subcutaneous biosimilars input 2024.07.30 14:55 input 2024.07.30 14:55 Views 0 Overview of Alteogen headquarters and research center (Photo = Alteogen) Alteogen announced on the 30th that it signed a joint development agreement for hyaluronidase with … Read more